From curing cancer to saving troubled LA Times, biotech billionaire Soon-Shiong has grand plans
Whether it's attempting to cure cancer or buying a troubled newspaper like the LA Times, Dr. Patrick Soon-Shiong has a penchant for the spotlight.
Whether it's attempting to cure cancer or buying a troubled newspaper like the LA Times, Dr. Patrick Soon-Shiong has a penchant for the spotlight.
NantWorks, the company of Patrick Soon-Shiong, has acquired a majority stake in Integrity Healthcare, Verity Health System's management company. Through the deal, NantWorks will become the operator of six California hospitals, including St. Vincent Medical Center.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Also, GSK chief bemoans lack of price transparency in the U.S., feds investigate pharma-PBM contracts and Memorial Hermann gets its first physician CEO.
NantHealth, the health IT, genomics and analytics division of Dr. Patrick Soon-Shiong's NantWorks operation, has finally filed for a long-awaited IPO.
An apparent highlight of the conference was U2 guitarist David "The Edge" Evans, who is active is several cancer charities, becoming the first rock star to play the Sistine Chapel.
Dr. Patrick Soon-Shiong spoke today at the Future of Genomic Medicine's 9th annual conference in San Diego. The obvious focus of his presentation was the Cancer Moonshot 2020 initiative.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Another load of cash - and little further insight - is on the books for Patrick Soon-Shiong cancer immunotherapy startup NantCell.
Dr. William Knaus, who created Health Heritage, has been executive director for clinical research informatics at NantHealth since September.
Dr. Patrick Soon-Shiong has two more fundraises under his companies' belt: According to an SEC filing, immuno-oncology startup NantCell has raised $100 million and precision medicine startup NantOmics has raised $150 million.
In a joint press release, NantHealth and Allscripts said that they would jointly integrate their software via application provider interfaces
The mysterious company just allocated $75 million to its NantCell division - putting some serious funding behind its precision medicine and cancer immunotherapy efforts.
Billionaire investor Patrick Soon-Shiong buys the rights to a next-gen Abraxane from Sorrento Therapeutics - building on the drug that launched his own fortune.
As we reported earlier, Dr. Patrick Soon-Shiong keynoted at the American Telemedicine Association’s annual meeting this past week. I also got a chance to meet with him for just a few minutes after his talk, and recorded the interview. In this recording, Soon-Shiong, the billionaire founder of NantWorks and NantHealth, expressed the belief that patients need to be more […]
Dr. Patrick Soon-Shiong has some big ideas in healthcare, like a vision of a fully connected ecosystem that truly empowers patients to make informed choices about their own care, aided by supercomputers to crunch all the data, including highly complex genomic information. And he's not afraid to toot his own horn every once in a while, he said Monday at the American Telemedicine Association's annual meeting.
Phoenix Children’s Hospital, with the help of a billionaire physician, is launching the Chan Soon-Shiong Children’s Precision Medicine Institute, which will include a cloud-based super computer that lets physicians utilize genome data that could help lead to more personalized treatments. The project is being backed by billionaire and pharmaceutical entrepreneur Dr. Patrick Soon-Shiong. It will […]